Cargando…

Performance of Interferon-Gamma Release Assays in the Diagnosis of Nontuberculous Mycobacterial Diseases—A Retrospective Survey From 2011 to 2019

There is an urgent need for precise diagnosis to distinguish nontuberculous mycobacterial (NTM) diseases from pulmonary tuberculosis (PTB) and other respiratory diseases. The aim of this study is to evaluate the diagnostic performance of Interferon-gamma (IFN-γ) release assays (IGRAs), including ant...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yang, Chi, Luo, Xuejiao, Fan, Lin, Sha, Wei, Xiao, Heping, Cui, Haiyan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2021
Materias:	Cellular and Infection Microbiology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7930076/ https://www.ncbi.nlm.nih.gov/pubmed/33680977 http://dx.doi.org/10.3389/fcimb.2020.571230

Ejemplares similares

Diagnostic Accuracy of Interferon-Gamma Release Assays for Tuberculous Meningitis: A Systematic Review and Meta-Analysis
por: Wen, An, et al.
Publicado: (2022)

Interferon-gamma release assays for diagnosis of latent TB infection in chronic kidney diseases and dialysis patients
por: Hayuk, Pattorn, et al.
Publicado: (2022)

Comparison of interferon gamma release assay and CXCL9 gene expression assay for the detection of Mycobacterium bovis infection in African lions (Panthera leo)
por: Gumbo, Rachiel, et al.
Publicado: (2022)

The performance of interferon-gamma release assay in nontuberculous mycobacterial diseases: a retrospective study in China
por: Wang, Mao-Shui, et al.
Publicado: (2016)

Increased Interferon-Induced Protein With Tetracopeptides (IFITs) Reduces Mycobacterial Growth
por: Madhvi, Abhilasha, et al.
Publicado: (2022)

DNA microarray chip assay in new use: early diagnostic value in cutaneous mycobacterial infection
por: Yu, Qian, et al.
Publicado: (2023)

Treatment Dilemmas in Disseminated Nontuberculous Mycobacterial Infections With Interferon-gamma Autoantibodies
por: King, Elizabeth M, et al.
Publicado: (2021)

Bortezomib treatment for refractory nontuberculous mycobacterial infection in the setting of interferon gamma autoantibodies
por: Rocco, Joseph M., et al.
Publicado: (2021)

Epidemiology of Nontuberculous Mycobacteria in Tuberculosis suspects, Southwest of China, 2017-2022
por: Wang, Dong-Mei, et al.
Publicado: (2023)

Comprehensive Determination of Mycobacterium tuberculosis and Nontuberculous Mycobacteria From Targeted Capture Sequencing
por: He, Ya, et al.
Publicado: (2020)

The Impact of Nontuberculous Mycobacteria Species on Mortality in Patients With Nontuberculous Mycobacterial Lung Disease
por: Wang, Ping-Huai, et al.
Publicado: (2022)

Mycobacterial Growth Inhibition Assay (MGIA) as a Host Directed Diagnostic Tool for the Evaluation of the Immune Response in Subjects Living With Type 2 Diabetes Mellitus
por: Bobadilla-del-Valle, Miriam, et al.
Publicado: (2021)

Performance evaluation and clinical validation of optimized nucleotide MALDI-TOF-MS for mycobacterial identification
por: Li, Baiying, et al.
Publicado: (2022)

Human Guanylate-Binding Protein 1 Positively Regulates Japanese Encephalitis Virus Replication in an Interferon Gamma Primed Environment
por: Chhabra, Simran, et al.
Publicado: (2022)

Terminal Respiratory Oxidases: A Targetables Vulnerability of Mycobacterial Bioenergetics?
por: Bajeli, Sapna, et al.
Publicado: (2020)

Using Omics to Study Leprosy, Tuberculosis, and Other Mycobacterial Diseases
por: Ahamad, Naseem, et al.
Publicado: (2022)

Airway epithelial cells mount an early response to mycobacterial infection
por: Barclay, Amy M., et al.
Publicado: (2023)

Reverse Transcription Recombinase-Aided Amplification Assay With Lateral Flow Dipstick Assay for Rapid Detection of 2019 Novel Coronavirus
por: Zheng, Yu-Zhong, et al.
Publicado: (2021)

Regulatory Mechanisms of Autophagy-Targeted Antimicrobial Therapeutics Against Mycobacterial Infection
por: Silwal, Prashanta, et al.
Publicado: (2021)

Editorial: Using omics to study leprosy, tuberculosis, and other mycobacterial diseases
por: de Macedo, Cristiana Santos, et al.
Publicado: (2022)

Interferon Gamma-Inducible Protein 16 of Peripheral Blood Mononuclear Cells May Sense Hepatitis B Virus Infection and Regulate the Antiviral Immunity
por: Lu, Yu-Qing, et al.
Publicado: (2021)

Editorial: Mycobacterial dormancy, culturability, and resuscitation: state-of-the-art, challenges, and future prospects
por: Salina, Elena G., et al.
Publicado: (2023)

Amidation of glutamate residues in mycobacterial peptidoglycan is essential for cell wall cross-linking
por: Shaku, Moagi T., et al.
Publicado: (2023)

Metagenomic next-generation sequencing assistance in identifying non-tuberculous mycobacterial infections
por: Wang, Shilei, et al.
Publicado: (2023)

Lipid droplets as multifunctional organelles related to the mechanism of evasion during mycobacterial infection
por: de Almeida, Patrícia Elaine, et al.
Publicado: (2023)

Evaluation of the IP-10 mRNA release assay for diagnosis of TB in HIV-infected individuals
por: Tang, Yang, et al.
Publicado: (2023)

Advances in Cardiovascular Disease Lipid Research Can Provide Novel Insights Into Mycobacterial Pathogenesis
por: Thirunavukkarasu, Shyamala, et al.
Publicado: (2019)

Uncovering interactions between mycobacterial respiratory complexes to target drug-resistant Mycobacterium tuberculosis
por: McNeil, Matthew B., et al.
Publicado: (2022)

DNA structural properties of DNA binding sites for 21 transcription factors in the mycobacterial genome
por: Dey, Upalabdha, et al.
Publicado: (2023)

Non-tuberculous mycobacterial disease: progress and advances in the development of novel candidate and repurposed drugs
por: Gu, Yuzhen, et al.
Publicado: (2023)

Mycobacterial Control of Host Mitochondria: Bioenergetic and Metabolic Changes Shaping Cell Fate and Infection Outcome
por: Mohareer, Krishnaveni, et al.
Publicado: (2020)

A novel STAT1 loss-of-function mutation associated with Mendelian susceptibility to mycobacterial disease
por: Ye, Fanghua, et al.
Publicado: (2022)

Case report: Diagnosis of Talaromyces marneffei infection in an HIV-negative patient with septic shock and high-titer anti-interferon gamma autoantibodies by metagenomic next-generation sequencing
por: Du, Rao, et al.
Publicado: (2023)

Hospitalization Risk for Medicare Beneficiaries With Nontuberculous Mycobacterial Pulmonary Disease
por: Prevots, D. Rebecca, et al.
Publicado: (2021)

Molecular Characterization of Dengue Virus Type 1 in Zhejiang in 2019
por: Yao, Wenwu, et al.
Publicado: (2021)

“It Takes Two to Tango”: Role of Neglected Macrophage Manipulators Coronin 1 and Protein Kinase G in Mycobacterial Pathogenesis
por: Saha, Saradindu, et al.
Publicado: (2020)

Mycobacterium tuberculosis Rv0790c inhibits the cellular autophagy at its early stage and facilitates mycobacterial survival
por: Fang, Jun, et al.
Publicado: (2022)

Rapid diagnosis of non-tuberculous mycobacterial pulmonary diseases by metagenomic next-generation sequencing in non-referral hospitals
por: Wang, Jing, et al.
Publicado: (2023)

Interferon-γ Autoantibodies as Predisposing Factor for Nontuberculous Mycobacterial Infection
por: Valour, Florent, et al.
Publicado: (2016)

Assessing Response to Therapy for Nontuberculous Mycobacterial Lung Disease: Quo Vadis?
por: Vinnard, Christopher, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_8m372dovsuqvd65o6o125fdgnu